The slip
PARKINSON RECEIPTno. 3335
19 Oct 2026, 17:39 UTCdopamine neurons, braak
predictionTLR7 in dopamine neurons tracks Braak Lewy-body stage
registerede36876d2b3dd4474
discovery+0.19 p=0.618 n=9
replication+0.28 p=0.470 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.19, p 0.618)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTac6de822ea5e5ec15b849eeb…
follows 5de394ce1efa…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3335: TLR7 in dopamine neurons, braak
- power
- full sample +0.23 (p 0.369, n 18), 95% CI -0.27 to +0.63. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.369, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.18 (p 0.471, n 18). could be the mix.
- skeptic
- leave-one-out range +0.11 to +0.32, sign flips 0; without severely affected donors +0.23 (p 0.369, n 18). fragile.
- cell type
- strongest in microglia: +0.59 (p 0.0092, n 18) vs +0.23 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TLR7 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TLR7 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.23 p 0.424 (needs p < 5.6e-4)